Picture of Pixium Vision SA logo

ALPIX — Pixium Vision SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Pixium Vision Receives Approval To Initiate European Primavera Pivotal Study Of Prima System

Nov 20 (Reuters) - Pixium Vision SA  ALPIX.PA :
    * PIXIUM VISION RECEIVES FRENCH REGULATORY AUTHORITY (ANSM)
APPROVAL TO INITIATE EUROPEAN PRIMAVERA PIVOTAL STUDY OF PRIMA
SYSTEM
    * STUDY WILL INCLUDE THREE YEARS OF FOLLOW-UP, WITH
ASSESSMENT OF
PRIMARY ENDPOINTS AT 12 MONTHS AFTER IMPLANTATION
    * EXPECTS TO REPORT 36-MONTH DATA OF THIS FEASIBILITY STUDY
BY
MID-2021

Source text for Eikon:  ID:nGNE9SWVhg 
Further company coverage:  ALPIX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Pixium Vision SA

See all news